Therapeutic evaluation of rutin in two-kidney one-clip model of renovascular hypertension in rat

Life Sciences

Volumn 150, Issue , 2016, Pages 89-94

  Kaur, Sandeep ^a   Muthuraman, Arunachalam ^a  

^a Akal College of Pharmacy and Technical Education   (India)

Author keywords

Aliskiren; Goldblatt method; Reduced glutathione; Rutin; Thiobarbituric acid; Two kidney one clip

Indexed keywords

ALISKIREN; GLUTATHIONE; RUTOSIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; AMIDE; ANTIHYPERTENSIVE AGENT; FUMARIC ACID DERIVATIVE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD VESSEL CLIP; BODY WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG SCREENING; HEART RATE; KIDNEY; KIDNEY MASS; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; RAT; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE; WEIGHT CHANGE; ANIMAL; BLOOD; BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECTS; HYPERTENSION, RENOVASCULAR; METABOLISM; ORGAN SIZE; SPRAGUE DAWLEY RAT;

AMIDES; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; FUMARATES; GLUTATHIONE; HEART RATE; HYPERTENSION, RENOVASCULAR; MALE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RENIN; RUTIN; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84959506769     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.02.080     Document Type: Article

References (68)

1. M.A. Alam, M.R. Chowdhury, P. Jain, M.A. Sagor, and H.M. Reza DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats Diabetol. Metab. Syndr. 7 2015 107
2. S. Banka, and W.G. Newman A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations Orphanet J. Rare Dis. 8 2013 84
3. K.B. Biswas, A.H. Nabi, Y. Arai, T. Nakagawa, A. Ebihara, A. Ichihara, T. Watanabe, T. Inagami, and F. Suzuki Aliskiren binds to renin and prorenin bound to (pro)renin receptor in vitro Hypertens. Res. 33 2010 1053 1059
4. M.A. Boegehold, I. Drenjancevic, and J.H. Lombard Salt, angiotensin II, superoxide, and endothelial function Compr. Physiol. 6 2015 215 254
5. R.M. Carey The intrarenal renin-angiotensin system in hypertension Adv. Chronic Kidney Dis. 22 2015 204 210
6. O. Cavalcanti Cde, R.R. Alves, A.L. de Oliveira, C. Cruz Jde, Mdo S. de Francą-Silva, A. Braga Vde, and Cde M. Balarini Inhibition of PDE5 restores depressed baroreflex sensitivity in renovascular hypertensive rats Front. Physiol. 7 2016 15
7. A. Chalkias, and T. Xanthos Intra-abdominal hypertension: A potent silent killer of cardiac arrest survivors Am. J. Emerg. Med. 30 2012 502 504
8. S.P. Chelko, C.W. Schmiedt, T.H. Lewis, S.J. Lewis, and T.P. Robertson A novel vascular clip design for the reliable induction of 2-kidney, 1-clip hypertension in the rat J. Appl. Physiol. 112 2012 362 366
9. H.K. Choi, L.C. Soriano, Y. Zhang, and L.A. Rodriguez Antihypertensive drugs and risk of incident gout among patients with hypertension: Population based case-control study BMJ 344 2012 d8190
10. A. Covic, and P. Gusbeth-Tatomir The role of the renin-angiotensin-aldosterone system in renal artery stenosis, renovascular hypertension, and ischemic nephropathy: Diagnostic implications Prog. Cardiovasc. Dis. 52 2009 204 208
11. A. Daugherty, D. Rateri, L. Hong, and A. Balakrishnan Measuring blood pressure in mice using volume pressure recording, a tail-cuff method J. Vis. Exp. 2009
12. R. Duarte, A. Carvalho, D. Gadelha, and V. Braga Rutin reduces oxidative stress in animals with renovascular hypertension BMC Proc. 8 2014 P65
13. G.L. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 1959 70 77
14. T. Fukai, and M. Ushio-Fukai Superoxide dismutases: Role in redox signaling, vascular function, and diseases Antioxid. Redox Signal. 15 2011 1583 1606
15. H. Goldblatt, J. Lynch, R.F. Hanzal, and W.W. Summerville Studies on experimental hypertension I. The production of persistent elevation of systolic blood pressure by means of renal ischemia J. Exp. Med. 59 1934 347 379
16. G. Gong, Y. Qin, W. Huang, S. Zhou, X. Yang, and D. Li Rutin inhibits hydrogen peroxide-induced apoptosis through regulating reactive oxygen species mediated mitochondrial dysfunction pathway in human umbilical vein endothelial cells Eur. J. Pharmacol. 628 2010 27 35
17. A.A. Gonzalez, and M.C. Prieto Renin and the (pro)renin receptor in the renal collecting duct: Role in the pathogenesis of hypertension Clin. Exp. Pharmacol. Physiol. 42 2015 14 21
18. N. Grobe, O. Leiva, M. Morris, and K.M. Elased Loss of prolyl carboxypeptidase in two-kidney, one-clip goldblatt hypertensive mice PLoS One 10 2015 e0117899
19. S.M. Hamza, and J.R. Dyck Systemic and renal oxidative stress in the pathogenesis of hypertension: Modulation of long-term control of arterial blood pressure by resveratrol Front. Physiol. 5 2014 292
20. S.M. Herrmann, A. Saad, A. Eirin, J. Woollard, H. Tang, M.A. McKusick, S. Misra, J.F. Glockner, L.O. Lerman, and S.C. Textor Differences in GFR and tissue oxygenation, and interactions between stenotic and contralateral kidneys in unilateral atherosclerotic renovascular disease Clin. J. Am. Soc. Nephrol. 2016
21. T.D. Hewitson, S.G. Holt, and E.R. Smith Animal models to study links between cardiovascular disease and renal failure and their relevance to human pathology Front. Immunol. 6 2015 465
22. C.N. Hsu, C.T. Lee, L.T. Huang, and Y.L. Tain Aliskiren in early postnatal life prevents hypertension and reduces asymmetric dimethylarginine in offspring exposed to maternal caloric restriction J. Renin-Angiotensin-Aldosterone Syst. 16 2015 506 513
23. Q.F. Huang, Y. Li, and J.G. Wang Overview of clinical use and side effect profile of valsartan in Chinese hypertensive patients Drug. Des. Devel. Ther. 8 2014 79 86
24. J.C. Ingram Jr., C. Marks, and L.W. Gray Jr. Surgically corrected renovascular hypertension secondary to traumatic renal artery stenosis: A human experimental model Am. Surg. 39 1973 642 644
25. K.T. Kang Endothelium-derived relaxing factors of small resistance arteries in hypertension Toxicol. Res. 30 2014 141 148
26. H. Kiyomoto, and K. Moriwaki Chronic blockade of the (pro)renin receptor ameliorates the kidney damage in the non-clipped kidney of Goldblatt hypertension Hypertens. Res. 34 2011 289 291
27. C.C. Lee, S.R. Shen, Y.J. Lai, and S.C. Wu Rutin and quercetin, bioactive compounds from tartary buckwheat, prevent liver inflammatory injury Food Funct. 4 2013 794 802
28. W. Lee, S.-K. Ku, and J.-S. Bae Barrier protective effects of rutin in LPS-induced inflammation in vitro and in vivo Food Chem. Toxicol. 50 2012 3048 3055
29. A.B. Levine, D. Punihaole, and T.B. Levine Characterization of the role of nitric oxide and its clinical applications Cardiology 122 2012 55 68
30. S. Loga-Zec, M. Asceric, N. Loga-Andrijic, B. Kapetanovic, and E. Zerem The incidence of antihypertensive drug-induced side effects in patients with diabetes mellitus type 2 and hypertension Med. Arch. 68 2014 372 375
31. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
32. M. Lu, Y.-H. Liu, H.S. Goh, J.J.X. Wang, Q.-C. Yong, R. Wang, and et al. Hydrogen sulfide inhibits plasma renin activity J. Am. Soc. Nephrol. 21 2010 993 1002
33. X. Lu, L.C. Roksnoer, and A.H.J. Danser The intrarenal renin-angiotensin system: Does it exist? Implications from a recent study in renal angiotensin-converting enzyme knockout mice Nephrol. Dial. Transplant. 28 2013 2977 2982
34. M. Mai, K.F. Hilgers, J. Wagner, J.F. Mann, and H. Geiger Expression of angiotensin-converting enzyme in renovascular hypertensive rat kidney Hypertension 25 1995 674 678
35. A. Martins-Oliveira, M.M. Castro, D.M. Oliveira, E. Rizzi, C.S. Ceron, D. Guimaraes, and et al. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling Int. J. Cardiol. 167 2013 1199 1205
36. J.Y. Moon Recent update of renin-angiotensin-aldosterone system in the pathogenesis of hypertension Electrolyte Blood Press. 11 2013 41 45
37. V.S. Negi, P. Devaraju, and R. Gulati Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism is not a risk factor for hypertension in SLE nephritis Clin. Rheumatol. 34 2015 1545 1549
38. N.T. Niture, A.A. Ansari, and S.R. Naik Anti-hyperglycemic activity of rutin in streptozotocin-induced diabetic rats: An effect mediated through cytokines, antioxidants and lipid biomarkers Indian J. Exp. Biol. 52 2014 720 727
39. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
40. S. Panda, and A. Kar Antithyroid effects of naringin, hesperidin and rutin in l-T4 induced hyperthyroid rats: Possible mediation through 5′DI activity Pharmacol. Rep. 66 2014 1092 1099
41. S. Paoli, and M.M. Mitsnefes Coronary artery calcification and cardiovascular disease in children with chronic kidney disease Curr. Opin. Pediatr. 26 2014 193 197
42. O. Petrák, T. Zelinka, B. Štrauch, J. Rosa, Z. Šomloóvá, T. Indra, H. Turková, R. Holaj, and J. Widimský Jr. Combination antihypertensive therapy in clinical practice. The analysis of 1254 consecutive patients with uncontrolled hypertension J. Hum. Hypertens. 30 2016 35 39
43. R.U. Pliquett, S. Benkhoff, O. Jung, and R.P. Brandes Sympathoactivation and rho-kinase-dependent baroreflex function in experimental renovascular hypertension with reduced kidney mass BMC Physiol. 14 2014 4
44. P. Ponchon, and J.L. Elghozi Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats Eur. J. Pharmacol. 297 1996 61 70
45. D.M. Ralapanawa, K.P. Jayawickreme, and E.M. Ekanayake A case of treatable hypertension: Fibromuscular dysplasia of renal arteries BMC Res. Notes 9 2016 6
46. M. Ranga Lakshmi Naidu, S. Jana, and S.M. Babu Antihypertensive effect of rutin hydrate in L-NAME induced hypertensive Sprague-Dawley rats IJUPBS 2013 151 161
47. N. Riva, and G.Y. Lip Which is the optimal antihypertensive combination in different diseases, a renin-angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker? Curr. Pharm. Des. 19 2013 3753 3765
48. C. Santuzz, R. Tiradentes, V. Mengal, E. Claudio, H. Mauad, S. Gouvea, and et al. Combined aliskiren and l-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension Braz. J. Med. Biol. Res. 48 2015 65 76
49. C.H. Santuzzi, R.V. Tiradentes, V. Mengal, E.R. Claudio, H. Mauad, S.A. Gouvea, and G.R. Abreu Combined aliskiren and l-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension Braz. J. Med. Biol. Res. 48 2015 65 76
50. A. Semplicini, T. Grandi, C. Sandona, A. Cattelan, and G. Ceolotto G-protein beta-subunit gene C825T polymorphism and cardiovascular risk: An updated review High Blood Press. Cardiovasc. Prev. 22 2015 225 232
51. M.M. Shafiq, D.V. Menon, and R.G. Victor Oral direct renin inhibition: Premise, promise, and potential limitations of a new antihypertensive drug Am. J. Med. 121 2008 265 271
52. J. Shanks, S. Manou-Stathopoulou, C.J. Lu, D. Li, D.J. Paterson, and N. Herring Cardiac sympathetic dysfunction in the prehypertensive spontaneously hypertensive rat Am. J. Physiol. Heart Circ. Physiol. 305 2013 H980 H986
53. T. Silambarasan, and B. Raja Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats Eur. J. Pharmacol. 679 2012 81 89
54. M. Singh, A. Kapoor, and A. Bhatnagar Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls Chem. Biol. Interact. 234 2015 261 273
55. T. Stompor Coronary artery calcification in chronic kidney disease: An update World J. Cardiol. 6 2014 115 129
56. C.Y. Sun, W.J. Cherng, H.Z. Jian, H.H. Hsu, I.W. Wu, H.J. Hsu, and M.S. Wu Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury beyond the direct renin inhibition Hypertens. Res. 35 2012 304 311
57. L.P. Svetkey, E.L. Harris, E. Martin, W.M. Vollmer, G.T. Meltesen, V. Ricchiuti, and et al. Modulation of the BP response to diet by genes in the renin-angiotensin system and the adrenergic nervous system Am. J. Hypertens. 24 2011 209 217
58. S.C. Textor, and M.M. McKusick Renal artery stenosis: If and when to intervene Curr. Opin. Nephrol. Hypertens. 25 2016 144 151
59. P.M. Thalanayar, I. Ghobrial, F. Lubin, R. Karnik, and R. Bhasin Drug-induced visceral angioedema J. Community Hosp. Intern. Med. Perspect. 4 2014
60. A. Tojo, S. Kinugasa, T. Fujita, and C.S. Wilcox A local renal renin-angiotensin system activation via renal uptake of prorenin and angiotensinogen in diabetic rats Diabetes Metab. Syndr. Obes. 9 2016 1 10
61. D.J. Van Twist, A.J. Houben, M.W. De Haan, G.J. Mostard, P.W. De Leeuw, and A.A. Kroon Angiotensin-(1-7)-induced renal vasodilation is reduced in human kidneys with renal artery stenosis J. Hypertens. 32 2014 2428 2432
62. P. Wal, A. Wal, A.K. Rai, and A. Dixit Aliskiren: An orally active renin inhibitor J. Pharm. Bioallied Sci. 3 2011 189 193
63. R. Wangensteen, F. O'Valle, R. Del Moral, F. Vargas, and A. Osuna Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats Med. Sci. Monit. 8 2002 BR378 BR384
64. S. Wu, J. Han, W.Q. Li, and A.A. Qureshi Hypertension, antihypertensive medication use, and risk of psoriasis JAMA Dermatol. 150 2014 957 963
65. N. Yahia, C. Brown, M. Rapley, and M. Chung Assessment of college students' awareness and knowledge about conditions relevant to metabolic syndrome Diabetol. Metab. Syndr. 6 2014 111
66. I.V. Yosipiv, and S.S. el-Dahr Activation of angiotensin-generating systems in the developing rat kidney Hypertension 27 1996 281 286
67. Y. Zhu, H.S. Wang, X.M. Li, and C. Qu Effects and mechanisms of fenofibrate on the secretion of vascular endothelial contraction factors in hypertensive rats Genet. Mol. Res. 13 2014 5269 5275
68. J.L. Zhuo, F.M. Ferrao, Y. Zheng, and X.C. Li New frontiers in the intrarenal renin-angiotensin system: A critical review of classical and new paradigms Front. Endocrinol. 4 2013 166